Recurrent intrahepatic cholangiocarcinoma: Single-center experience using repeated hepatectomy and radiofrequency ablation

Journal of Hepato-Biliary-Pancreatic Sciences

Volumn 17, Issue 4, 2010, Pages 509-515

  Kamphues, Carsten ^a   Seehofer, D ^a   Eisele, R M ^a   Denecke, T ^a   Pratschke, J ^a   Neumann, U P ^a   Neuhaus, P ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Intrahepatic cholangiocarcinoma; Radiofrequency ablation; Recurrence; Repeated liver resection

Indexed keywords

DOXORUBICIN; GEMCITABINE;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER SURVIVAL; CLINICAL ARTICLE; COHORT ANALYSIS; DISEASE FREE SURVIVAL; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; INTRAHEPATIC CHOLANGIOCARCINOMA; LIVER RESECTION; MALE; OUTCOME ASSESSMENT; PATIENT SAFETY; RADIOFREQUENCY ABLATION; RECURRENT CANCER; REOPERATION; RETROSPECTIVE STUDY; SURVIVAL TIME; BILE DUCT TUMOR; BIOPSY; CATHETER ABLATION; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; GERMANY; INCIDENCE; INTRAHEPATIC BILE DUCT; METHODOLOGY; MIDDLE AGED; MORTALITY; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; AGED; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; BIOPSY; CATHETER ABLATION; CHOLANGIOCARCINOMA; FEMALE; FOLLOW-UP STUDIES; GERMANY; HEPATECTOMY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; REOPERATION; RETROSPECTIVE STUDIES; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 79952114556     PISSN: 18686974     EISSN: 18686982     Source Type: Journal    
DOI: 10.1007/s00534-009-0256-6     Document Type: Article

References (25)

1. Ustundag Y, Bayraktar Y. Cholangiocarcinoma: a compact review of the literature. World J Gastroenterol. 2008; 14(42):6458-66.
2. Endo I, Gonen M, Yopp AC, Dalal KM, Zhou Q, Klimstra D, et al. Intrahepatic cholangiocarcinoma. Rising frequency, improved survival, and determinants of outcome after resection. Ann Surg. 2008;248(1):84-96.
3. De Oliveira ML, Cunningham SC, Cameron JL, et al. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg. 2007;245:755-62. (Pubitemid 46684105)
4. Hammill CW, Wong LL. Intrahepatic cholangiocarcinoma: a malignancy of increasing importance. J Am Coll Surg. 2008;207:594-603.
5. Chu KM, Lai EC, Al-Hadeedi S, Arcilla CE, Lo CM, Liu CL, et al. Intrahepatic cholangiocarcinoma. World J Surg. 1997;21:301-5.
6. Shimada K, Sano T, Sakamoto Y, et al. Surgical outcomes of the mass-forming plus periductal infiltrating types of intrahepatic cholangiocarcinoma: a comparative study with the typical massforming type of intrahepatic cholangiocarcinoma. World J Surg. 2007;31:2016-22. (Pubitemid 47415732)
7. Jonas S, Thelen A, Benckert C, Biskup W, Neumann UP, Rudolph B, et al. Extended liver resection for intrahepatic cholangiocarcinoma: a comparison of the prognostic accuracy of the fifth and sixth editions of the TNM classification. Ann Surg. 2009;249:303-9.
8. Shimota M, Kubota K. Multi-disciplinary treatment for cholangiocellular carcinoma. World J Gastroenterol. 2007; 13(10):1500-4. (Pubitemid 46672656)
9. Tamandl D, Herberger B, Gruenberger B, Puhalla H, Klinger M, Gruenberger T. Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma. Ann Surg Oncol. 2008;15(10):2787-94.
10. Yamamoto M, Takasaki K, Otsubo T, Katsuragawa H, Katagiri S. Recurrence after surgical resection of intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg. 2001;8:154-7. (Pubitemid 33690530)
11. Khan SA, Davidson BR, Goldin R, et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut. 2002;51:1-9.
12. Seehofer D, Kamphues C, Neuhaus P. Management of bile duct cancer. Expert Opin Pharmacother. 2008;9:2843-56.
13. Weber SM, Janargin WR, Klimstra D, et al. Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes. J Am Coll Surg. 2001;193:384-91. (Pubitemid 32895979)
14. Lang H, Sotiropoulos GC, Frühauf NR, Dömland M, Paul A, Kind EM, et al. Extended hepatectomy for intrahepatic cholangiocellular carcinoma (ICC): when is it worthwhile? Single center experience with 27 resections in 50 patients over a 5-year period. Ann Surg. 2005;241:134-43. (Pubitemid 40041002)
15. Kurosaki I, Hatakeyama K. Repeated hepatectomy for recurrent intrahepatic cholangiocarcinoma: report of two cases. Eur J Gastroenterol Hepatol. 2005;17:125-30. (Pubitemid 40128937)
16. Saiura A, Yamamoto J, Kokudo N, Koga R, Seki M, Hiki N, Yamada K, Natori T, Yamaguchi T. Intrahepatic cholangiocarcinoma: analysis of 44 consecutive resected cases including 5 cases with repeat resections. Am J Surg. 2009. doi: 10.1016/j.amjsurg.2008.12.035
17. Ohtsuka M, Kimura F, Shimizu H, Yoshidome H, Kato A, Yoshitomi H, et al. Significance of repeated resection for recurrent intrahepatic cholangiocarcinoma. Hepatogastroenterology. 2009;56(89):1-5.
18. Curley SA, Izzo F, Ellis LM, Nicolas VJ, Vallone P. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg. 2000;232:381-91.
19. Lu MD, Yin XY, Xie XY, Xu HX, Xu ZF, Liu GJ, et al. Percutaneous thermal ablation for recurrent hepatocellular carcinoma after hepatectomy. Br J Surg. 2005;92:1393-8.
20. Chen MS, Li JQ, Zheng Y, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg. 2006;243:321-8. (Pubitemid 43327762)
21. Lau WY, Lai ECH. The current role of radiofrequency ablation in the management of hepatocellular carcinoma: a systematic review. Ann Surg. 2009;249(1):20-5.
22. Taura K, Ikai I, Hatano E, et al. Implication of frequent local ablation therapy for intrahepatic recurrence in prolonged survival of patients with hepatocellular carcinoma undergoing hepatic resection: an analysis of 610 patients over 16 years old. Ann Surg. 2006;244:265-73. (Pubitemid 44305542)
23. Slakey DP. Radiofrequency ablation of recurrent cholangiocarcinoma. Ann Surg. 2002;68:395-7. (Pubitemid 44971292)
24. Fan WJ, Wu PH, Zhang L, Huang JH, Zhang FJ, Gu YK, et al. Radiofrequency ablation as a treatment for hilar cholangiocarcinoma. World J Gastroenterol. 2008;14(28):4540-5.
25. Zgodzinski W, Espat NJ. Radiofrequency ablation for incidentally identified primary intrahepatic cholangiocarcinoma. World J Gastroenterol. 2005;11(33):5239-40. (Pubitemid 41410349)